(MRKR) |
| 0 (0%) 08-26 13:50 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 1.86 |
| Resistance 1: | 1.59 |
| Pivot price: | 1.25 |
| Support 1: | 1.26 |
| Support 2: | 1.05 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | -0.380 |
| Book Value | 0.730 |
| PEG Ratio | 0.00 |
| Gross Profit | -0.108 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | -385.95 |
| Return on Assets (ttm) | -44.1 |
| Return on Equity (ttm) | -76.9 |
Company news
Mon, 24 Aug 2026
Is Marker Therapeutics (NASDAQ:MRKR) In A Good Position To Deliver On Growth Plans? - simplywall.st
Fri, 14 Aug 2026
MRKR Advances 2.7% to $1.14 as Biotech Stock Holds Above Key Support - PSAR Stop - dars.gov.et
Thu, 13 Aug 2026
CCORF Maintains Marker Therapeutics(MRKR.US) With Buy Rating, Maintains Target Price $8 - Moomoo
Fri, 10 Jul 2026
Wainwright reiterates Buy on Marker Therapeutics stock, $10 target - Investing.com
Thu, 02 Jul 2026
Marker Therapeutics, Inc.'s (NASDAQ:MRKR) Profit Outlook - simplywall.st
Fri, 26 Jun 2026
MRKR Forecast — Price Target — Prediction for 2027 - TradingView
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
